EP1513870A4 - Cftr-modifier-gene und exprimierte polypeptide, die sich für die behandlung von cystischer fibrose eignen, und verfahren und produkte zu deren nachweis und/ oder identifikation - Google Patents

Cftr-modifier-gene und exprimierte polypeptide, die sich für die behandlung von cystischer fibrose eignen, und verfahren und produkte zu deren nachweis und/ oder identifikation

Info

Publication number
EP1513870A4
EP1513870A4 EP03734252A EP03734252A EP1513870A4 EP 1513870 A4 EP1513870 A4 EP 1513870A4 EP 03734252 A EP03734252 A EP 03734252A EP 03734252 A EP03734252 A EP 03734252A EP 1513870 A4 EP1513870 A4 EP 1513870A4
Authority
EP
European Patent Office
Prior art keywords
identifying
products
detecting
treatment
cystic fibrosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03734252A
Other languages
English (en)
French (fr)
Other versions
EP1513870A2 (de
Inventor
Jeffrey Allen Whitsett
Bruce Jefferson Aronow
Jean Cantwell Clark
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cincinnati Childrens Hospital Medical Center
Original Assignee
Cincinnati Childrens Hospital Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cincinnati Childrens Hospital Medical Center filed Critical Cincinnati Childrens Hospital Medical Center
Publication of EP1513870A2 publication Critical patent/EP1513870A2/de
Publication of EP1513870A4 publication Critical patent/EP1513870A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4712—Cystic fibrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
EP03734252A 2002-05-31 2003-05-30 Cftr-modifier-gene und exprimierte polypeptide, die sich für die behandlung von cystischer fibrose eignen, und verfahren und produkte zu deren nachweis und/ oder identifikation Withdrawn EP1513870A4 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US38485502P 2002-05-31 2002-05-31
US38485602P 2002-05-31 2002-05-31
US384855P 2002-05-31
US384856P 2002-05-31
PCT/US2003/016896 WO2003102140A2 (en) 2002-05-31 2003-05-30 Cftr modifier genes and expressed polypeptides useful in treating cystic fibrosis

Publications (2)

Publication Number Publication Date
EP1513870A2 EP1513870A2 (de) 2005-03-16
EP1513870A4 true EP1513870A4 (de) 2006-06-07

Family

ID=29715352

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03734252A Withdrawn EP1513870A4 (de) 2002-05-31 2003-05-30 Cftr-modifier-gene und exprimierte polypeptide, die sich für die behandlung von cystischer fibrose eignen, und verfahren und produkte zu deren nachweis und/ oder identifikation

Country Status (6)

Country Link
EP (1) EP1513870A4 (de)
JP (1) JP2005528449A (de)
CN (1) CN1671734A (de)
AU (1) AU2003238791A1 (de)
CA (1) CA2488012A1 (de)
WO (1) WO2003102140A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101392026B (zh) * 2008-10-09 2011-11-09 黄岚 用于预防和治疗纤维化类疾病以及肝癌的多肽
CA2793877A1 (en) * 2010-03-22 2011-09-29 Esoterix Genetic Laboratories, Llc Mutations associated with cystic fibrosis
JP6049719B2 (ja) * 2011-08-05 2016-12-21 カウンスィル オブ サイエンティフィック アンド インダストリアル リサーチＣｏｕｎｃｉｌ Ｏｆ Ｓｃｉｅｎｔｉｆｉｃ ＆ Ｉｎｄｕｓｔｒｉａｌ Ｒｅｓｅａｒｃｈ Ａｎｉｓｏｃｈｉｌｕｓｖｅｒｔｉｃｉｌｌａｔｕｓ由来のピマランジテルペン
WO2014058974A1 (en) * 2012-10-10 2014-04-17 Emory University Methods of managing inflammation using glycolysis pathway inhibitors
RS57739B1 (sr) * 2013-03-14 2018-12-31 Translate Bio Inc Kompozicije cftr irnk i postupci i upotrebe u vezi sa njima
CN109280704A (zh) * 2018-10-12 2019-01-29 郑州大学第附属医院 Rasd1作为标志物在制备b-all诊断和预后评估试剂盒中的应用
CA3116015A1 (en) * 2018-10-30 2020-05-07 University Of Florida Research Foundation, Incorporated Amino acid compositions and methods for treating cystic fibrosis
CN113604583B (zh) * 2021-08-10 2024-04-02 河南省畜牧总站 一种山羊kcnj15基因cnv标记辅助检测生长性状的方法及其专用试剂盒
US20240076682A1 (en) * 2022-08-29 2024-03-07 Universita' Degli Studi Di Bari Aldo Moro Promoter of the transcription of nucleic acid sequence an its use

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
GOSSET P ET AL: "A New Inward Rectifier Potassium Channel Gene (KCNJ15) Localized on Chromosome 21 in the Down Syndrome Chromosome Region 1 (DCR1)", GENOMICS, ACADEMIC PRESS, SAN DIEGO, US, vol. 44, no. 2, 1 September 1997 (1997-09-01), pages 237 - 241, XP004459193, ISSN: 0888-7543 *
RIORDAN J R: "IDENTIFICATION OF THE CYSTIC FIBROSIS GENE: CLONING AND CHARACTERIZATION OF COMPLEMENTARY DNA", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, US, vol. 245, no. 4922, 8 September 1989 (1989-09-08), pages 1066 - 1073, XP000068211, ISSN: 0036-8075 *
THIERY E ET AL: "Developmentally regulated expression of the murine ortholog of the potassium channel KIR4.2 (KCNJ15)", MECHANISMS OF DEVELOPMENT, vol. 95, no. 1-2, July 2000 (2000-07-01), pages 313 - 316, XP002375674, ISSN: 0925-4773 *

Also Published As

Publication number Publication date
CN1671734A (zh) 2005-09-21
WO2003102140A2 (en) 2003-12-11
JP2005528449A (ja) 2005-09-22
EP1513870A2 (de) 2005-03-16
WO2003102140A3 (en) 2004-06-10
CA2488012A1 (en) 2003-12-11
AU2003238791A1 (en) 2003-12-19

Similar Documents

Publication Publication Date Title
DE60317268D1 (de) Verfahren zum extrudieren von brotteig und danach erhältliche produkte
DE60334664D1 (de) System und Verfahren zum Nachweis von biologischem und chemischem Material
DE60327545D1 (de) Prozess für das produktion von photochromen überlagerten produkte
DE60208278D1 (de) System und Verfahren zum Testen von Nukleinsäuremolekülen
DE69828245D1 (de) Chitinperlen, chitosanperlen, verfahren zu ihren herstellung, trägermaterialien darauf hergestellte und verfahren von mikrosporen
DE60215743D1 (de) Verfahren und Rechnerprogrammprodukt zur Lagebestimmung von Gesichtsmerkmalen
DE60132480D1 (de) Verfahren zum formen von schichtbonbons, und nach diesem verfahren erhaltene produkte
NO20023050L (no) Fremgangsmåte samt anlegg for utf degree relse av fremgangsmåten
DE60224128D1 (de) Vorrichtung und Verfahren zum Erkennen von Zeichen und mathematischen Ausdrücken
DE602004002195D1 (de) Verfahren und apparat für die ablauffolgesteuerung von paketen
DE60316454D1 (de) Verfahren und dosierformen für die kontrollierte abgabe von paliperidon
NO20014271D0 (no) Fremgangsmåte og anordning for fremstilling av börstevarer, og börstevarer fremstilt ved bruk av disse
DE60039396D1 (de) Gerät und Verfahren zum Vergleichen von Fingerabdrücken
DE60029876D1 (de) Verfahren und Oligonukleotide zum Nachweis von Nukleinsäuresequenzvariationen
DE60320718D1 (de) Vorrichtung und Verfahren zum Messen von Oberflächenprofilen
DE60114763D1 (de) Verfahren und Vorrichtung für filtern von Zugriff, und Computerprodukt
EP1513870A4 (de) Cftr-modifier-gene und exprimierte polypeptide, die sich für die behandlung von cystischer fibrose eignen, und verfahren und produkte zu deren nachweis und/ oder identifikation
DE602004022030D1 (de) Verfahren und vorrichtung zum walzen von metallplattenmaterial
DE60311075D1 (de) Einstufenverfahren zum rotationsformen von uniformen streckmetall
DE60206447D1 (de) Verfahren und Vorrichtung zum Ausbalancieren von Superkapazitäten
DE60218967D1 (de) Verfahren und Vorrichtung zum Zusammensetzen von Furnierstreifen
DE602004027183D1 (de) Verfahren zum Formen von Verdrahtung und Elektrode
ATE269529T1 (de) Verfahren zur behandlung von abgasen in der stahlindustrie
DE50202777D1 (de) Vorrichtung und Verfahren zum Mischen von flüssigen, zähflüssigen und/oder rieselfähigen Medien
EP1508097A4 (de) Verfahren und implementierung für die nachrichtengesteuerte job-verarbeitung

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20041223

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

D17P Request for examination filed (deleted)
DAX Request for extension of the european patent (deleted)
R17P Request for examination filed (corrected)

Effective date: 20041223

RBV Designated contracting states (corrected)

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

A4 Supplementary search report drawn up and despatched

Effective date: 20060425

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20060714